Combination of Sorafenib and Intensity Modulated Radiotherapy for Unresectable Hepatocellular Carcinoma

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.29, Iss.1, 2009-01, pp. : 65-71

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sorafenib: In Hepatocellular Carcinoma

By Simpson Dene Keating Gillian M.

Drugs, Vol. 68, Iss. 2, 2008-01 ,pp. : 251-258

Adis International

Access to resources Recommend Favorite

Selection of Patients with Hepatocellular Carcinoma for Sorafenib

By Abou-Alfa Ghassan K.

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 7, Iss. 4, 2009-04 ,pp. : 397-403

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Phase 1 trial of S-1 in combination with sorafenib for patients with advanced hepatocellular carcinoma

By Lee Su

Investigational New Drugs, Vol. 30, Iss. 4, 2012-08 ,pp. : 1540-1547

Springer Publishing Company

Access to resources Recommend Favorite

Combination of oxaliplatin and S-1 versus sorafenib alone in patients with advanced hepatocellular carcinoma

Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol. 69, Iss. 10, 2014-10 ,pp. : 759-763

Govi-Verlag

Access to resources Recommend Favorite

Sequential therapy with sunitinib and sorafenib in metastatic hepatocellular carcinoma

By Ahn Hee

Investigational New Drugs, Vol. 30, Iss. 4, 2012-08 ,pp. : 1768-1772

Springer Publishing Company

Access to resources Recommend Favorite